Rozrolimupab, a first-in-class recombinant monoclonal antibody product for primary immune thrombocytopaenia

Author: Easdale Sandra   Stasi Roberto  

Publisher: Informa Healthcare

ISSN: 1471-2598

Source: Expert Opinion on Biological Therapy, Vol.13, Iss.7, 2013-09, pp. : 1085-1092

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content